Critical limb Ischaemia Associated with Chemotherapy for Breast Cancer

Keefe D.L. , Roistacher N. , Pierri M.K. Clinical cardiotoxicity of 5-fluorouracil. J Clin Pharmacol 1993; 33: 1060–70

Lestuzzi C. , Viel E. , Picano E. , Meneguzzo N. Coronary vasospasm as a cause of effort-related myocardial ischemia during low-dose chronic continuous infusion of 5-fluorouracil. Am J Med 2001; 111: 316–18

Kleiman N.S. , Lehane D.E. , Geyer C.E. Jr. , Pratt C.M. , Young J.B. Prinzmetal's angina during 5-fluorouracil chemotherapy. Am J Med 1987; 82: 566–8

Mosseri M. , Fingert H.J. , Varticovski L. , Chokshi S. , Isner J.M. In vitro evidence that myocardial ischemia resulting from 5-fluorouracil chemotherapy is due to protein kinase C-mediated vasoconstriction of vascular smooth muscle. Cancer Res 1993; 53: 3028–33

Becker K. , Erckenbrecht J.F. , Haussinger D. , Frieling T. Cardiotoxicity of the antiproliferative compound fluorouracil. Drugs 1999; 57: 475–84

Kinhult S. , Albertsson M. , Eskilsson J. , Cwikiel M. Effects of probucol on endothelial damage by 5-fluorouracil. Acta Oncologica 2003; 42: 304–8

Papamichael D. , Amft N. , Slevin M.L. , D'Cruz D. 5-Fluorouracil-induced Raynaud's phenomenon. Eur J Cancer 1998; 34: 1983